Rapid Assessment and Containment of Candida auris Transmission in Postacute Care Settings—Orange County, California, 2019
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Background: Candida auris, a multidrug-resistant yeast, can spread rapidly in ventilator-capable skilled-nursing facilities (vSNFs) and long-term acute care hospitals (LTACHs). In 2018, a laboratory serving LTACHs in southern California began identifying species of Candida that were detected in urine specimens to enhance surveillance of C auris, and C auris was identified in February 2019 in a patient in an Orange County (OC), California, LTACH. Further investigation identified C auris at 3 associated facilities. Objective: To assess the prevalence of C auris and infection prevention and control (IPC) practices in LTACHs and vSNFs in OC. Design: Point prevalence surveys (PPSs), postdischarge testing for C auris detection, and assessments of IPC were done from March to October 2019. Setting: All LTACHs (n = 3) and vSNFs (n = 14) serving adult patients in OC. Participants: Current or recent patients in LTACHs and vSNFs in OC. Intervention: In facilities where C auris was detected, PPSs were repeated every 2 weeks. Ongoing IPC support was provided. Measurements: Antifungal susceptibility testing and whole-genome sequencing to assess isolate relatedness. Results: Initial PPSs at 17 facilities identified 44 additional patients with C auris in 3 (100%) LTACHs and 6 (43%) vSNFs, with the first bloodstream infection reported in May 2019. By October 2019, a total of 182 patients with C auris were identified by serial PPSs and discharge testing. Of 81 isolates that were sequenced, all were clade III and highly related. Assessments of IPC identified gaps in hand hygiene, transmission-based precautions, and environmental cleaning. The outbreak was contained to 2 facilities by October 2019. Limitation: Acute care hospitals were not assessed, and IPC improvements over time could not be rigorously evaluated. Conclusion: Enhanced laboratory surveillance and prompt investigation with IPC support enabled swift identification and containment of C auris. Primary Funding Source: Centers for Disease Control and Prevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662 · cited 9×
“Most C auris isolates are resistant to fluconazole, and resistance to amphotericin B and echinocandins has already been identified in C auris strains globally and in the United States (3, 4, 10), making C auris amultidrug-resistant organism (MDRO) of concern.”
BackgroundResultInfluentialSelf-citationMicroreact: visualizing and sharing data for genomic epidemiology and phylogeography
Argimón, S., Abudahab, K., Goater, R. J. E., Fedosejev, A., Bhai, J., Glasner, C., Feil, E. J., Holden, M. T. G., Yeats, C. A., Grundmann, H., et al. (2016) · Microbial Genomics · doi:10.1099/mgen.0.000093 · Cited by 732 · cited 6×
“vSNF A 2/18 (11) 9/10 (90) 16/25 (64) 12/20 (60) B 8/24 (33) 10/11 (91) 19/25 (76) 18/24 (75) C Unknown (33) 10/13 (77) 7/13 (54) Unknown (83) D 6/7 (86) –‡ 13/25 (52) –‡”
InfluentialA Candida auris Outbreak and Its Control in an Intensive Care Setting
Eyre, D. W., Sheppard, A. E., Madder, H., Moir, I., Moroney, R., Quan, T. P., Griffiths, D., George, S., Butcher, L., Morgan, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714373 · Cited by 517 · cited 2×
“Illness acuity Full assistance with mobility 21 (66) 17 (85) 38 (73) Hospitalization within 6 mo 28 (88) 11 (55) 39 (75) Documented antibiotic exposure 8 (25) 1 (5) 9 (17)”
BackgroundChow, N. A., Muñoz, J. F., Gade, L., Berkow, E., Li, X., Welsh, R. M., Forsberg, K., Lockhart, S. R., Adam, R., Alanio, A., et al. (2020) · doi:10.1101/2020.01.06.896548 · Cited by 463
Self-citationMuñoz, J. F., Gade, L., Chow, N. A., Loparev, V. N., Juieng, P., Berkow, E. L., Farrer, R. A., Litvintseva, A. P., & Cuomo, C. A. (2018) · Nature Communications · doi:10.1038/s41467-018-07779-6 · Cited by 458
Self-citationCandida auris : The recent emergence of a multidrug-resistant fungal pathogen
Forsberg, K., Woodworth, K., Walters, M., Berkow, E. L., Jackson, B., Chiller, T., & Vallabhaneni, S. (2019) · Medical Mycology · doi:10.1093/mmy/myy054 · Cited by 421 · cited 14×
“Most C auris isolates are resistant to fluconazole, and resistance to amphotericin B and echinocandins has already been identified in C auris strains globally and in the United States (3, 4, 10), making C auris amultidrug-resistant organism (MDRO) of concern.”
BackgroundInfluentialSelf-citationVallabhaneni, S., Kallen, A., Tsay, S., Chow, N., Welsh, R., Kerins, J., Kemble, S. K., Pacilli, M., Black, S. R., Landon, E., et al. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6544e1 · Cited by 302
Self-citationChow, N. A., Gade, L., Tsay, S. V., Forsberg, K., Greenko, J. A., Southwick, K. L., Barrett, P. M., Kerins, J. L., Lockhart, S. R., Chiller, T. M., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30597-8 · Cited by 289
Self-citationCandida auris in Healthcare Facilities, New York, USA, 2013–2017
Adams, E., Quinn, M., Tsay, S., Poirot, E., Chaturvedi, S., Southwick, K., Greenko, J., Fernandez, R., Kallen, A., Vallabhaneni, S., et al. (2018) · Emerging Infectious Diseases · doi:10.3201/eid2410.180649 · Cited by 284 · cited 2×
“However, because C auris frequently colonizes nonsterile body sites (14, 20), species identification of Candida from these sites can enable detection of C auris and facilitate implementation of measures to prevent transmission.”
BackgroundSelf-citationCandida auris Outbreak in a COVID-19 Specialty Care Unit — Florida, July–August 2020
Prestel, C., Anderson, E., Forsberg, K., Lyman, M., de Perio, M. A., Kuhar, D., Edwards, K., Rivera, M., Shugart, A., Walters, M., et al. (2021) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7002e3 · Cited by 237 · cited 4×
“Gaps in IPC that likely contributed to C auris transmission included use of ABHS on gloved hands; inadequate HH; and contamination of the local environment, shared medical equipment, and computers due to extended use of gowns and gloves (38).”
BackgroundResultInfluentialSelf-citation
Cited by
Worsening Spread of Candida auris in the United States, 2019 to 2021
Lyman, M., Forsberg, K., Sexton, D. J., Chow, N. A., Lockhart, S. R., Jackson, B. R., & Chiller, T. (2023) · Annals of Internal Medicine · doi:10.7326/m22-3469 · Cited by 287
“The response to initial cases of C auris in Orange County, California, in 2019 illustrates how early detection followed by screening and IPC interventions can minimize spread (44).”
BackgroundSelf-citationKeighley, C., Garnham, K., Harch, S. A. J., Robertson, M., Chaw, K., Teng, J. C., & Chen, S. C.-A. (2021) · Current Fungal Infection Reports · doi:10.1007/s12281-021-00420-y · Cited by 87
Mechanisms of pathogenicity for the emerging fungus Candida auris
Horton, M. V., Holt, A. M., & Nett, J. E. (2023) · PLOS Pathogens · doi:10.1371/journal.ppat.1011843 · Cited by 67
The many faces of Candida auris: Phenotypic and strain variation in an emerging pathogen
Santana, D. J., Zhao, G., & O’Meara, T. R. (2024) · PLOS Pathogens · doi:10.1371/journal.ppat.1012011 · Cited by 62
Psychogenetic, genetic and epigenetic mechanisms in Candida auris: Role in drug resistance
Rabaan, A. A., Eljaaly, K., Alfouzan, W. A., Mutair, A. A., Alhumaid, S., Alfaraj, A. H., Aldawood, Y., Alsaleh, A. A., Albayat, H., Azmi, R. A., et al. (2023) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2022.12.012 · Cited by 14
Metadata
- Authors
- Karmarkar, E. N., O’Donnell, K., Prestel, C., Forsberg, K., Gade, L., Jain, S., Schan, D., Chow, N., McDermott, D., Rossow, J., Toda, M., Ruiz, R., Hun, S., Dale, J. L., Gross, A., Maruca, T., Glowicz, J., Brooks, R., Bagheri, H., Nelson, T., Gualandi, N., Khwaja, Z., Horwich-Scholefield, S., Jacobs, J., Cheung, M., Walters, M., Jacobs-Slifka, K., Stone, N. D., Mikhail, L., Chaturvedi, S., Klein, L., Vagnone, P. S., Schneider, E., Berkow, E. L., Jackson, B. R., Vallabhaneni, S., Zahn, M., & Epson, E.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2021-11
- Volume
- 174
- Issue
- 11
- Pages
- 1554-1562
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W3198560505
- Cited by
- 38
- References
- 11
- FWCI
- 1.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.